Chondrosarcoma natural history: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 8: | Line 8: | ||
*Chondrosarcoma is associated with a 5 year survival rate of 75%. | *Chondrosarcoma is associated with a 5 year survival rate of 75%. | ||
*Depending upon the subtype, prognosis vary substantially: | *Depending upon the subtype, prognosis vary substantially: | ||
**Chondrosarcoma NOS | **Chondrosarcoma NOS: 5 year survival of approximately 70%. | ||
**Mesenchymal chondrosarcoma | **Myxoid chondrosarcoma: 5 year survival of approximately 70%. | ||
**Dedifferentiated chondrosarcoma | **Mesenchymal chondrosarcoma: 5 year survival of approximately 50%. | ||
**Dedifferentiated chondrosarcoma: 5 year survival of 0%. | |||
==References== | ==References== |
Revision as of 17:46, 28 August 2015
Chondrosarcoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Chondrosarcoma natural history On the Web |
American Roentgen Ray Society Images of Chondrosarcoma natural history |
Risk calculators and risk factors for Chondrosarcoma natural history |
Overview
Complications
Chondrosarcoma may return and may need treatment with surgery, chemotherapy or radiation.
Prognosis
- Generally, chondrosarcoma carries a good prognosis.
- Chondrosarcoma is associated with a 5 year survival rate of 75%.
- Depending upon the subtype, prognosis vary substantially:
- Chondrosarcoma NOS: 5 year survival of approximately 70%.
- Myxoid chondrosarcoma: 5 year survival of approximately 70%.
- Mesenchymal chondrosarcoma: 5 year survival of approximately 50%.
- Dedifferentiated chondrosarcoma: 5 year survival of 0%.